RE:RE:RE:RE:Bayer looking for a "mid-size M&A transaction" in oncologyJune 14, 2024 - "The [biopharma] industry is staring down a looming patent cliff like it’s a massive hurricane inching toward landfall. And the patent cliff not too far in the distance is set to be one of the most harrowing in history."
With the industry facing this onslaught of challenges, pharma companies are battening the hatches through increased partnerships [M&A] and at times, bigger deals. But as the Economist recently noted, surging demand for attractive drug candidates and companies is triggering soaring premiums in M&A."
https://www.pharmavoice.com/news/pharma-patent-cliff-Merck-Keytruda-Pfizer-Seagen-Humira/652914/